Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: More than 0.5 million catheter days and 7 years of clinical experience*
Elizabeth Ramos(The University of Texas MD Anderson Cancer Center), Issam Raad(Missouri Department of Agriculture), Ann Marie Chaftari(The University of Texas MD Anderson Cancer Center), Joseph L. Nates(The University of Texas MD Anderson Cancer Center), Ray Hachem(The University of Texas MD Anderson Cancer Center), Brenda Hackett(The University of Texas MD Anderson Cancer Center), Jeffrey J. Tarrand, Roy F. Chemaly(The University of Texas MD Anderson Cancer Center), Ying Jiang(The University of Texas MD Anderson Cancer Center), S. Egbert Pravinkumar(The University of Texas MD Anderson Cancer Center), Ruth Reitzel(The University of Texas MD Anderson Cancer Center)
Cited by 83
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Guidelines for the Management of Intravascular Catheter-Related Infections
|Clinical Infectious Diseases|2001|1.5k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806